bpc-157 randomized clinical trial humans BPC-157: What the Science Actually Says Stable Gastric Pentadecapeptide BPC 157
Description
The researchers own conclusion was that it was well absorbed. Why that number is the whole ballgame: ~38% of an oral dose reaching circulation is a genuinely good absorption fraction for an oral compound plenty of approved oral products sit at or below that
Changes in intestinal microbiota in the form of increases in -diversity and increase in the abundance of non-commensals or less dominant taxa correlate with an increased intestinal permeability [12]
The primary assumptions were that BPC-157 is highly stable, biocompatible, and sufficient to exert action when presented by itself
Most users tolerate it well
